These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19018837)

  • 21. Paroxysmal choreoathetosis: report of five cases and review of the literature.
    Kinast M; Erenberg G; Rothner AD
    Pediatrics; 1980 Jan; 65(1):74-7. PubMed ID: 7355039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preprogramming motor dysfunction in paroxysmal kinesigenic choreoathetosis.
    Fattapposta F; My F; Valente D; Quadrini R; D'Alessio C; Amabile G
    Funct Neurol; 2003; 18(1):29-34. PubMed ID: 12760411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of conductive education combined with Frenkel training on balance disability in children with cerebral palsy].
    Yang L; Wu D; Tang JL; Jin L; Li XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):207-9. PubMed ID: 19292961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control?
    Erasmus CE; Van Hulst K; Rotteveel LJ; Jongerius PH; Van Den Hoogen FJ; Roeleveld N; Rotteveel JJ
    Dev Med Child Neurol; 2009 Jun; 51(6):454-9. PubMed ID: 19207297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical manifestation and carbamazepine treatment of patients with paroxysmal kinesigenic choreoathetosis.
    Tsai JD; Chou IC; Tsai FJ; Kuo HT; Tsai CH
    Acta Paediatr Taiwan; 2005; 46(3):138-42. PubMed ID: 16231560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrabenazine in the treatment of severe pediatric chorea.
    Chatterjee A; Frucht SJ
    Mov Disord; 2003 Jun; 18(6):703-6. PubMed ID: 12784277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of botulinum toxin A in children with cerebral palsy.
    Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
    Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy.
    Monbaliu E; Ortibus E; De Cat J; Dan B; Heyrman L; Prinzie P; De Cock P; Feys H
    Dev Med Child Neurol; 2012 Mar; 54(3):278-83. PubMed ID: 22428172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accidental overdosage of levetiracetam in two children caused no side effects.
    Awaad Y
    Epilepsy Behav; 2007 Sep; 11(2):247. PubMed ID: 17692573
    [No Abstract]   [Full Text] [Related]  

  • 30. Pervasive developmental disorders in individuals with cerebral palsy.
    Kilincaslan A; Mukaddes NM
    Dev Med Child Neurol; 2009 Apr; 51(4):289-94. PubMed ID: 19335564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Birth-related syndromes of athetosis and kernicterus.
    Przekop A; Sanger TD
    Handb Clin Neurol; 2011; 100():387-95. PubMed ID: 21496597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of levetiracetam in a child with nonconvulsive status epilepticus.
    Alehan F; Ozcay F; Haberal M
    J Child Neurol; 2008 Mar; 23(3):331-3. PubMed ID: 18192652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF; Crisp ED; Kayani S; Rajab H
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of levetiracetam in hemifacial spasm: a case report.
    Biagio Carrieri P; Petracca M; Montella S
    Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam-induced diffuse interstitial lung disease.
    Newsome SD; Xue LY; Jennings T; Castaneda GY
    J Child Neurol; 2007 May; 22(5):628-30. PubMed ID: 17690072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of diazepam on athetosic children with cerebral palsy].
    Claverie P; Ousset A; Cahusac M; Nichil J; Bayrou
    Rev Neuropsychiatr Infant; 1968 Dec; 16(12):925-30. PubMed ID: 5714897
    [No Abstract]   [Full Text] [Related]  

  • 38. A systematic review of scales to measure dystonia and choreoathetosis in children with dyskinetic cerebral palsy.
    Stewart K; Harvey A; Johnston LM
    Dev Med Child Neurol; 2017 Aug; 59(8):786-795. PubMed ID: 28485494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levetiracetam in the treatment of vascular chorea: a case report.
    D'Amelio M; Callari G; Gammino M; Saia V; Lupo I; Salemi G; Ragonese P; Savettieri G
    Eur J Clin Pharmacol; 2005 Jan; 60(11):835-6. PubMed ID: 15580486
    [No Abstract]   [Full Text] [Related]  

  • 40. The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
    Mintz M; Legoff D; Scornaienchi J; Brown M; Levin-Allen S; Mintz P; Smith C
    J Child Neurol; 2009 Jul; 24(7):807-15. PubMed ID: 19189934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.